Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 214 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Liakopoulos, Vassilios  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Georgianos, P. I., Sarafidis P. A., Karpetas A., Kosmidis D., Sioulis A., Liakopoulos V., et al. (2014).  Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures.. Blood Purif. 37(1), 18-26.
Georgianos, P. I., Mpoutsiouki F., Sabani E., Stamatiadis D. N., Liakopoulos V., Balaskas E. V., et al. (2016).  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.. Int Urol Nephrol. 48(4), 601-8.
Liakopoulos, V., Jeron A., Shah A., Bruder D., Mertens P. R., & Gorny X. (2018).  Hemodialysis-related changes in phenotypical features of monocytes.. Sci Rep. 8(1), 13964.
Georgianos, P. I., Champidou E., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.. J Am Soc Hypertens. 12(4), 242-247.
Duni, A., Dounousi E., Pavlakou P., Eleftheriadis T., & Liakopoulos V. (2020).  Hypertension in Chronic Kidney Disease: Novel Insights.. Curr Hypertens Rev. 16(1), 45-54.
Georgianos, P. I., Vaios V., Sgouropoulou V., Eleftheriadis T., Tsalikakis D. G., & Liakopoulos V. (2022).  Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology.. Diagnostics (Basel). 12(12), 
I
Liakopoulos, V., Georgianos P. I., Demirtzi P., Vaios V., Kalathas T., & Zebekakis P. E. (2018).  Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report.. BMC Nephrol. 19(1), 293.
Eleftheriadis, T., Pissas G., Liakopoulos V., & Stefanidis I. (2018).  IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation.. Int J Mol Med. 42(1), 557-568.
Nikitidou, O., Daskalopoulou E., Papagianni A., Vlachogiannis E., Dombros N., & Liakopoulos V. (2020).  The impact of OSA and CPAP treatment on cell adhesion molecules' night-morning variation.. Sleep Breath.
Liakopoulos, V., Stefanidis I., & Mertens P. R. (2018).  The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis.. Am J Kidney Dis. 72(2), 309.
Eleftheriadis, T., Sounidaki M., Pissas G., Antoniadi G., Liakopoulos V., & Stefanidis I. (2016).  In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets.. Mol Med Rep. 13(4), 3370-6.
Eleftheriadis, T., Pissas G., Mavropoulos A., Nikolaou E., Filippidis G., Liakopoulos V., et al. (2020).  In Mixed Lymphocyte Reaction, the Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat Suppresses Cellular and Humoral Alloimmunity.. Arch Immunol Ther Exp (Warsz). 68(6), 31.
Eleftheriadis, T., Pissas G., Antoniadi G., Tsogka K., Makri P., Liakopoulos V., et al. (2016).  Increased Indoleamine 2,3-Dioxygenase in Monocytes of Patients on Hemodialysis.. Iran J Kidney Dis. 10(2), 91-3.
Eleftheriadis, T., Kartsios C., Pissas G., Liakopoulos V., Antoniadi G., Galaktidou G., et al. (2013).  Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients.. Ther Apher Dial. 17(1), 48-54.
Eleftheriadis, T., Pissas G., Remoundou M., Antoniadi G., Liakopoulos V., & Stefanidis I. (2013).  Increased visfatin in hemodialysis patients is associated with decreased demands for recombinant human erythropoietin.. Ren Fail. 35(10), 1399-403.
Rouka, E., Liakopoulos V., Gourgoulianis K. I., Hatzoglou C., & Zarogiannis S. G. (2019).  In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria.. Medicina (Kaunas). 55(8), 
Eleftheriadis, T., Pissas G., Liakopoulos V., & Stefanidis I. (2018).  Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.. Iran J Allergy Asthma Immunol. 17(1), 56-67.
Eleftheriadis, T., Pissas G., Sounidaki M., Tsogka K., Antoniadis N., Antoniadi G., et al. (2016).  Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.. Int J Mol Med. 38(5), 1605-1613.
Eleftheriadis, T., Pissas G., Golfinopoulos S., Liakopoulos V., & Stefanidis I. (2022).  Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells.. J Basic Clin Physiol Pharmacol.
Eleftheriadis, T., Pissas G., Antoniadi G., Liakopoulos V., & Stefanidis I. (2015).  Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.. Immunology. 146(2), 292-300.
Eleftheriadis, T., Pissas G., Antoniadi G., Spanoulis A., Liakopoulos V., & Stefanidis I. (2014).  Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.. Int Immunol. 26(12), 673-84.
Eleftheriadis, T., Liakopoulos V., Antoniadi G., Stefanidis I., & Galaktidou G. (2011).  Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination.. Vaccine. 29(12), 2242-7.
Sounidaki, M., Pissas G., Eleftheriadis T., Antoniadi G., Golfinopoulos S., Liakopoulos V., et al. (2019).  Indoleamine 2,3-dioxygenase suppresses humoral alloimmunity via pathways that different to those associated with its effects on T cells.. Biomed Rep. 1(1), 1-5.
Eleftheriadis, T., Pissas G., Yiannaki E., Markala D., Arampatzis S., Antoniadi G., et al. (2013).  Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutaminolysis in alloreactive T-cells.. Hum Immunol. 74(12), 1501-9.
Eleftheriadis, T., Pissas G., Liakopoulos V., & Stefanidis I. (2013).  Inhibition of indoleamine 2,3-dioxygenase not only blocks autoreactive B cell activation, but it also reduces production of antibodies in general: comment on the article by Pigott and Mandik-Nayak.. Arthritis Rheum. 65(7), 1951-2.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές